the longest one patient waited for treatment following a gp referral in 2017 was 541 days - against a target of 62 days.
.
orchid pharma faces liquidation as lenders reject resolution plan
.
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.